Quintiles Transitional Holdings Inc. (NYSE:Q) insider Kevin C. Knightly sold 20,000 shares of the business’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the completion of the transaction, the insider now owns 46,826 shares of the company’s stock, valued at $4,227,451.28. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of Quintiles Transitional Holdings Inc. (NYSE:Q) traded up 1.53% during mid-day trading on Friday, hitting $88.91. 1,006,508 shares of the stock traded hands. The stock has a 50 day moving average price of $90.07 and a 200-day moving average price of $83.42. The company has a market cap of $19.25 billion, a P/E ratio of 257.71 and a beta of 0.64. Quintiles Transitional Holdings Inc. has a one year low of $70.10 and a one year high of $93.53.

Quintiles Transitional Holdings (NYSE:Q) last issued its earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The business had revenue of $1.97 billion during the quarter, compared to analysts’ expectations of $1.96 billion. During the same quarter in the previous year, the business earned $0.93 EPS. The company’s revenue for the quarter was up 68.7% on a year-over-year basis. On average, analysts forecast that Quintiles Transitional Holdings Inc. will post $4.58 earnings per share for the current fiscal year.

Quintiles Transitional Holdings announced that its Board of Directors has initiated a share buyback program on Wednesday, May 24th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the medical research company to buy up to 5.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: “Insider Selling: Quintiles Transitional Holdings Inc. (NYSE:Q) Insider Sells 20,000 Shares of Stock” was published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/insider-selling-quintiles-transitional-holdings-inc-nyseq-insider-sells-20000-shares-of-stock/1475185.html.

A number of equities analysts have weighed in on Q shares. Zacks Investment Research cut shares of Quintiles Transitional Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, April 26th. Mizuho upped their price objective on shares of Quintiles Transitional Holdings from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Thursday, May 4th. Evercore ISI restated an “in-line” rating and set a $88.50 price objective (up from $84.00) on shares of Quintiles Transitional Holdings in a research report on Thursday, May 4th. Jefferies Group LLC restated a “hold” rating and set a $81.00 price objective (up from $78.00) on shares of Quintiles Transitional Holdings in a research report on Friday, May 5th. Finally, Credit Suisse Group restated an “outperform” rating and set a $96.00 price objective (up from $94.00) on shares of Quintiles Transitional Holdings in a research report on Tuesday, June 6th. Eleven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Quintiles Transitional Holdings currently has a consensus rating of “Hold” and a consensus target price of $89.94.

Hedge funds have recently modified their holdings of the company. ProShare Advisors LLC boosted its stake in shares of Quintiles Transitional Holdings by 2.5% in the second quarter. ProShare Advisors LLC now owns 2,920 shares of the medical research company’s stock worth $261,000 after buying an additional 71 shares during the last quarter. Buffington Mohr McNeal boosted its position in Quintiles Transitional Holdings by 0.5% in the first quarter. Buffington Mohr McNeal now owns 14,425 shares of the medical research company’s stock worth $1,162,000 after buying an additional 75 shares in the last quarter. Shell Asset Management Co. boosted its position in Quintiles Transitional Holdings by 1.0% in the first quarter. Shell Asset Management Co. now owns 8,769 shares of the medical research company’s stock worth $706,000 after buying an additional 83 shares in the last quarter. Oppenheimer & Co. Inc. boosted its position in Quintiles Transitional Holdings by 0.7% in the second quarter. Oppenheimer & Co. Inc. now owns 11,315 shares of the medical research company’s stock worth $1,013,000 after buying an additional 84 shares in the last quarter. Finally, Bbva Compass Bancshares Inc. boosted its position in Quintiles Transitional Holdings by 4.2% in the second quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock worth $197,000 after buying an additional 88 shares in the last quarter. Institutional investors and hedge funds own 91.83% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.